Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells

Abstract Monoclonal antibodies (mAbs) have emerged as targeted immunotherapies with clinical effectiveness and low adverse effects for various cancers. However, antibody drugs for treating aggressive T cell malignancies, T lymphoblastic leukemia/lymphoma (T-ALL/T-LBL), are still limited. Therefore,...

詳細記述

書誌詳細

主要な著者:	Kamonporn Kotemul, Ratthakorn Chaiwut, Chaochetdhapada Putpim, Supansa Pata, Witida Laopajon, Chatchai Tayapiwatana, Watchara Kasinrerk, Nuchjira Takheaw
フォーマット:	Artigo
言語:	Inglês
出版事項:	Springer 2025-04-01
シリーズ:	Discover Oncology
主題:	Monoclonal antibody CD99 molecule Cancer immunotherapy T lymphoblastic leukemia/lymphoma Anticancer activities Immune effector functions
オンライン･アクセス:	https://doi.org/10.1007/s12672-025-02281-0
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!